SKYE - Skye Bioscience Inc
IEX Last Trade
6.17
-0.220 -3.566%
Share volume: 50,319
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$6.39
-0.22
-3.44%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
4.03%
1 Month
13.58%
3 Months
-46.87%
6 Months
163.40%
1 Year
163.40%
2 Year
163.40%
Key data
Stock price
$6.17
DAY RANGE
N/A - N/A
52 WEEK RANGE
$2.29 - $17.65
52 WEEK CHANGE
$1.63
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/11/2024
Company detail
CEO: Brian Murphy
Region: US
Website: https://www.emeraldbio.life/
Employees: 11
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://www.emeraldbio.life/
Employees: 11
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
nemus bioscience is a publicly traded, life-science biotech company, developing regulatory-approved, cannabinoid-based therapies, for a spectrum of diseases, especially those of unmet medical need.
Recent news